Terug
Dagbereik
€ 2,13
€ 2,60
52-Weeksbereik
€ 0,86
€ 2,80
Volume
11.639.138
50D / 200D Gem.
€ 2,01
/
€ 1,45
Vorige Slotkoers
€ 2,07
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,9 | 0,4 |
| P/B | 1,9 | 2,9 |
| ROE % | -53,4 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,3 | 0,2 |
Koersdoel Analisten
Hold
€ 29,00
+1088.5%
Low: € 7,00
High: € 55,00
Forward WPA
-€ 0,80
Omzet Sch.
17000
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,90
€ 0,90 – € 0,90
|
650 M | 4 |
| FY2029 |
-€ 0,03
-€ 0,03 – -€ 0,03
|
340 M | 4 |
| FY2028 |
-€ 0,70
-€ 1,02 – -€ 0,27
|
110 M | 10 |
Belangrijkste Punten
Debt/Equity of 0,26 — conservative balance sheet
Negative free cash flow of -149,63M
PEG of 0,05 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-53,42%
ROIC-42,22%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,26
Current Ratio7,93
Interest Coverage-192,50
Waardering
P/E Ratio
-2,87
P/B Ratio1,87
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -190,89M |
| ROE | -53,42% | ROA | -45,90% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -149,63M |
| ROIC | -42,22% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,26 | Current Ratio | 7,93 |
| Interest Coverage | -192,50 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -2,87 | P/B Ratio | 1,87 |
| P/S Ratio | N/A | PEG Ratio | 0,05 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 548,34M | Enterprise Value | 571,70M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 22.000,0 | 95.000,0 | 156.000,0 | 114,09M |
| Net Income | -190,89M | -257,59M | -327,27M | -340,41M | -182,05M |
| EPS (Diluted) | -0,87 | -1,32 | -2,09 | -2,38 | -1,34 |
| Gross Profit | -12,36M | 22.000,0 | 95.000,0 | -14,14M | 114,09M |
| Operating Income | -206,93M | -273,20M | -327,74M | -335,54M | -180,19M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 415,91M | 548,71M | 642,84M | 821,58M | 1,05B |
| Total Liabilities | 123,36M | 126,53M | 130,60M | 154,70M | 125,63M |
| Shareholders' Equity | 292,54M | 422,18M | 512,23M | 666,88M | 925,20M |
| Total Debt | 75,05M | 90,76M | 95,12M | 101,12M | 73,13M |
| Cash & Equivalents | 51,69M | 75,22M | 83,16M | 61,90M | 173,31M |
| Current Assets | 257,75M | 303,39M | 459,12M | 528,82M | 471,32M |
| Current Liabilities | 32,51M | 35,52M | 37,08M | 53,73M | 47,91M |